Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs AJANTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA AJANTA PHARMA CIPLA/
AJANTA PHARMA
 
P/E (TTM) x 34.2 23.8 144.0% View Chart
P/BV x 4.3 4.9 88.5% View Chart
Dividend Yield % 0.4 0.8 58.8%  

Financials

 CIPLA   AJANTA PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-22
AJANTA PHARMA
Mar-22
CIPLA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0831,614 67.1%   
Low Rs8061,089 74.1%   
Sales per share (Unadj.) Rs269.7391.1 69.0%  
Earnings per share (Unadj.) Rs31.783.4 38.0%  
Cash flow per share (Unadj.) Rs44.898.1 45.6%  
Dividends per share (Unadj.) Rs5.009.50 52.6%  
Avg Dividend yield %0.50.7 75.3%  
Book value per share (Unadj.) Rs257.8382.1 67.5%  
Shares outstanding (eoy) m806.8185.42 944.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.53.5 101.4%   
Avg P/E ratio x29.816.2 183.9%  
P/CF ratio (eoy) x21.113.8 153.2%  
Price / Book Value ratio x3.73.5 103.6%  
Dividend payout %15.811.4 138.4%   
Avg Mkt Cap Rs m762,177115,433 660.3%   
No. of employees `000NANA-   
Total wages/salary Rs m35,2996,458 546.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m217,63333,410 651.4%  
Other income Rs m3,2171,157 278.1%   
Total revenues Rs m220,85134,567 638.9%   
Gross profit Rs m43,2989,293 465.9%  
Depreciation Rs m10,5201,253 839.6%   
Interest Rs m1,064102 1,042.6%   
Profit before tax Rs m34,9339,095 384.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,3381,968 474.5%   
Profit after tax Rs m25,5957,127 359.1%  
Gross profit margin %19.927.8 71.5%  
Effective tax rate %26.721.6 123.5%   
Net profit margin %11.821.3 55.1%  
BALANCE SHEET DATA
Current assets Rs m147,10824,548 599.3%   
Current liabilities Rs m49,1298,377 586.5%   
Net working cap to sales %45.048.4 93.0%  
Current ratio x3.02.9 102.2%  
Inventory Days Days6342 150.3%  
Debtors Days Days611 51.5%  
Net fixed assets Rs m119,41519,259 620.0%   
Share capital Rs m1,614172 939.8%   
"Free" reserves Rs m206,36432,469 635.6%   
Net worth Rs m207,97732,640 637.2%   
Long term debt Rs m4,16216 25,380.5%   
Total assets Rs m266,52343,807 608.4%  
Interest coverage x33.890.2 37.5%   
Debt to equity ratio x00 3,983.3%  
Sales to assets ratio x0.80.8 107.1%   
Return on assets %10.016.5 60.6%  
Return on equity %12.321.8 56.4%  
Return on capital %17.028.2 60.3%  
Exports to sales %26.20-   
Imports to sales %8.20-   
Exports (fob) Rs m57,094NA-   
Imports (cif) Rs m17,803NA-   
Fx inflow Rs m60,18018,678 322.2%   
Fx outflow Rs m17,8033,662 486.1%   
Net fx Rs m42,37615,016 282.2%   
CASH FLOW
From Operations Rs m33,2595,620 591.8%  
From Investments Rs m-18,719-741 2,526.2%  
From Financial Activity Rs m-15,998-4,600 347.8%  
Net Cashflow Rs m-1,323279 -474.3%  

Share Holding

Indian Promoters % 13.5 70.5 19.1%  
Foreign collaborators % 20.1 0.0 -  
Indian inst/Mut Fund % 49.4 21.4 231.1%  
FIIs % 27.7 8.2 336.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.4 29.5 224.9%  
Shareholders   388,864 62,048 626.7%  
Pledged promoter(s) holding % 0.0 17.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    


More on Cipla vs AJANTA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs AJANTA PHARMA Share Price Performance

Period Cipla AJANTA PHARMA S&P BSE HEALTHCARE
1-Day -0.40% 1.00% -0.10%
1-Month -3.39% -7.10% -1.99%
1-Year 21.55% -11.49% -5.62%
3-Year CAGR 34.11% 23.72% 20.96%
5-Year CAGR 13.48% 7.01% 11.47%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the AJANTA PHARMA share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.6% stake in the company. In case of AJANTA PHARMA the stake stands at 70.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of AJANTA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of 15.8%.

AJANTA PHARMA paid Rs 9.5, and its dividend payout ratio stood at 11.4%.

You may visit here to review the dividend history of Cipla, and the dividend history of AJANTA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.